Show results for
Refine by
Immune Rejection Equipment & Supplies
13 equipment items found
Manufactured by:Altucell, Inc. based inNew York, NEW YORK (USA)
Microcapsules constitute immunoisolatory physical barriers that prevent immune rejection of the enveloped cells upon graft, while offering a special 3D Cell matrix like microenvironment (which greatly favors retention of cell viability and ...
Manufactured by:HEALIOS K.K. based inTokyo, JAPAN
A universal donor cell is a kind of cell that can be used for transplantation into anyone. In other words, it is a cell in which the induction of immune rejection*１ (Human Leukocyte Antigen（HLA*２）mismatch) has been suppressed, and which can be used for patients requiring transplants ...
Manufactured by:Vascudyne, Inc. based inStillwater, MINNESOTA (USA)
Bioprosthetic heart valves may have addressed some of the limitations of mechanical valves but still carry their own: gradual degeneration such as pannus growth, leaflet fibrosis and calcification, delamination of the connective tissue, and emergence of ruptures and perforations all eventually lead to valve failure (Kostyunin et al, 2020). While structural valve degeneration is under ongoing ...
Manufactured by:Nano Intelligent Biomedical Engineering Corporations (NIBEC) Co., Ltd. based inJincheon-gun, SOUTH KOREA
Manufactured by removing organic components and purifying only inorganic bone mineral, OCS-H has a low rate of inflammation and immune rejection. It is a biocompatible bone graft material that is made from equine bone, of which structure is almost the same as human bone, so that it can be easily compatible with surrounding bone tissue when grafted. OCS-H bone ...
Manufactured by:Celularity Inc. based inFlorham Park, NEW JERSEY (USA)
Celularity’s unique technology realizes the full promise of cell therapies by harnessing the immunomodulatory and regenerative properties of the postpartum ...
Manufactured by:Infomed SA based inMeinier, SWITZERLAND
TPE allows to remove patient’s plasma from the blood and to replace it with fluids which do not contain the large substances, such as antibodies, targeted to be removed. It applies to a wide range of acute diseases but more rarely to chronic ones due to the adverse effects of the replacement fluids, human albumin or fresh frozen plasma, ...
Manufactured by:Isto Biologics based inHopkinton, MASSACHUSETTS (USA)
Inforce™ is a line of flexible, lightweight, dehydrated amniotic membrane sheets. Acting as a protective barrier to aid in wound management, Inforce™ provides scaffold, growth factors, and is ...
Manufactured by:Singleron Biotechnologies GmbH based inKöln, GERMANY
Singleron's sCircle technology enables full length V(D)J region sequencing at single cell level with short-read ...
Manufactured by:Infomed SA based inMeinier, SWITZERLAND
Like TPE, cascade filtration and DFPP allow to remove the larger substances from the blood, such as antibodies, fibrinogen or LDL-cholesterol. Its interest remains in the fact that the plasma is filtered and then returned to the patient, avoiding or minimizing the need for replacement fluids. Thus, cascade filtration/DFPP applies to both acute and chronic ...
Manufactured by:Universal Cells Inc. based inSeattle, WASHINGTON (USA)
Universal Cells uses recombinant Adeno-Associated Virus (rAAV)-mediated gene editing to engineer chromosomal genes without the use of genotoxic nucleases. Serotype 3B rAAV vectors efficiently infect pluripotent stem cells and their single-stranded DNA genomes pair with homologous chromosomal sequences during replication to precisely alter human genomic ...
Manufactured by:HEALIOS K.K. based inTokyo, JAPAN
Induced pluripotent stem cells (iPSCs) are established by introducing several factors to somatic cells such as skin cells. iPSCs can differentiate into the cells of a various tissues or organs (pluripotency) and grow indefinitely (proliferation). The objective of iPSC regenerative medicine is to restore cellular function by replacing dysfunctional tissues with cell therapy medicines, which are ...
by:Longeveron, Inc. based inMiami, FLORIDA (USA)
Lomecel-B is made from special living cells called Medicinal Signaling Cells, or MSCs that are isolated from fresh bone marrow tissue that has been donated by adult donors aged 18 to 45. Because the cells come from another individual, Lomecel-B is referred to as an “allogeneic” (donor-derived) ...
Manufactured by:Hemostemix Inc. based inCalgary, ALBERTA (CANADA)
Hemostemix’s technology uses a patient’s own cells to treat that patient’s disease. The cornerstone of this autologous technology is a novel cell population within the blood called the synergetic cell population (SCP). The synergetic cell population, which can be collected from a simple blood draw, consists of progenitor and other supporting cells that are being developed for ...